INCOGEN Receives Second-year Funding for Cancer Diagnostics Research.WILLIAMSBURG, Va. -- INCOGEN has announced that the company has successfully met their first-year milestones and received the remaining $1.2 million of a two-year, $2 Million award from the National Institutes of Health - National Cancer Institute to continue its research program in cancer diagnostics. The research program involves a close collaboration with scientists from the College of William and Mary Noun 1. William and Mary - joint monarchs of England; William III and Mary II and clinical researchers from the Eastern Virginia Medical School Eastern Virginia Medical School, in Norfolk, Virginia is a public medical school. . The award is a Phase II follow-on to a previous grant which INCOGEN received from the NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. in 2003. The Phase I award provided funding for INCOGEN and its academic collaborators to develop a pilot project in the analysis of data obtained from surface-enhanced laser desorption Desorption A process in which atomic and molecular species residing on the surface of a solid leave the surface and enter the surrounding gas or vacuum. ionization ionization: see ion. ionization Process by which electrically neutral atoms or molecules are converted to electrically charged atoms or molecules (ions) by the removal or addition of negatively charged electrons. (SELDI SELDI Surface Enhanced Laser Desorption/Ionization ) mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. . This approach may provide alternative, highly accurate, methods for screening for cancers that currently require highly invasive diagnoses, such as prostate cancer or leukemia. SELDI was developed by the Fremont, CA-based company, Ciphergen, who make and distribute the instruments used for this research. Please visit this link for more information: http://www.incogen.com/index.php?type=General¶m=cancer+diagnostics Under the award, both institutions will perform subcontracts to INCOGEN. The data will be produced at EVMS EVMS Enterprise Volume Management System EVMS Eastern Virginia Medical School EVMS Earned Value Management System EVMS Earned Value Management Standard EVMS Embedded Voice Mail System EVMS Enterprise Vulnerability Management System and analyzed at both INCOGEN and W&M. The goal of the Phase II research is to develop a ready-to-use, clinical diagnostic software package, based on INCOGEN's highly successful Visual Integrated Bioinformatics Environment (VIBE) software. The new software product will be distributed to clinical researchers involved in diagnostic work. About INCOGEN: INCOGEN, Inc. provides state-of-the-art software and industry-leading professional services to scientists involved in pharmaceutical, agricultural and biotechnology research. The suite of INCOGEN tools includes GenePort(R), a web-browser-based information mining and management portal; VIBE(TM), an extensible bioinformatics visual programming and workflow management platform; and HDFR(TM) and Magelan(TM), two image analysis software packages. INCOGEN Professional Services provide scientists with industry-leading technological expertise to assist researchers with every phase of design, development and implementation of their informatics infrastructures. The company is committed to supplying the research community with tools to optimize the analysis, mining, and management of life science data. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion